Dyrlægegruppen Skjern Å-Videbæk ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.3% 2.2% 2.8% 3.2% 1.8%  
Credit score (0-100)  66 65 57 55 71  
Credit rating  BBB BBB BB BB BBB  
Credit limit (kDKK)  0.1 0.1 0.0 0.0 2.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  6,006 6,155 5,890 5,694 6,740  
EBITDA  1,607 1,586 1,133 1,133 2,238  
EBIT  1,320 1,334 885 885 2,095  
Pre-tax profit (PTP)  1,336.1 1,338.8 878.0 878.0 2,092.7  
Net earnings  1,044.3 1,036.4 682.3 682.3 1,625.3  
Pre-tax profit without non-rec. items  1,336 1,339 878 878 2,093  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9

Tangible assets total  347 352 179 179 153  
Shareholders equity total  1,206 1,143 801 801 1,777  
Interest-bearing liabilities  66.5 0.0 117 117 0.0  
Balance sheet total (assets)  2,531 2,591 1,766 1,766 3,325  

Net Debt  66.5 -185 117 117 -1,441  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  6,006 6,155 5,890 5,694 6,740  
Gross profit growth  -3.0% 2.5% -4.3% -3.3% 18.4%  
Employees  9 8 9 9 8  
Employee growth %  0.0% -11.1% 12.5% 0.0% -11.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,531 2,591 1,766 1,766 3,325  
Balance sheet change%  -42.7% 2.4% -31.8% 0.0% 88.2%  
Added value  1,319.7 1,333.9 885.2 885.2 2,095.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -1,016 -667 -549 -376 -168  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  22.0% 21.7% 15.0% 15.5% 31.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  38.9% 52.7% 40.9% 50.4% 82.8%  
ROI %  59.3% 111.7% 86.4% 96.9% 156.5%  
ROE %  47.7% 88.2% 70.2% 85.1% 126.1%  

Solidity 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
Equity ratio %  47.7% 44.1% 45.4% 45.4% 53.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  4.1% -11.7% 10.3% 10.3% -64.4%  
Gearing %  5.5% 0.0% 14.6% 14.6% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  38.2% 32.7% 21.2% 10.6% 27.2%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
Quick Ratio  1.1 1.1 1.3 1.3 1.8  
Current Ratio  1.3 1.3 1.6 1.6 2.0  
Cash and cash equivalent  0.0 185.1 0.0 0.0 1,441.3  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  432.9 492.7 581.6 581.6 1,582.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2022/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  147 167 98 98 262  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  179 198 126 126 280  
EBIT / employee  147 167 98 98 262  
Net earnings / employee  116 130 76 76 203